Nanocapsulated quercetin downregulates rat hepatic MMP-13 and controls diethylnitrosamine-induced carcinoma

Nanomedicine

Volumn 9, Issue 15, 2014, Pages 2323-2337

  Mandal, Ardhendu Kumar ^a   Ghosh, Debasree ^a   Sarkar, Sibani ^a   Ghosh, Aparajita ^a   Swarnakar, Snehasikta ^a   Das, Nirmalendu ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

diethyl nitrosamine; hepatocarcinogenesis; MMP 13; nanocapsulated quercetin; proinflammatory cytokines; reactive oxygen species

Indexed keywords

COLLAGENASE 3; DIETHYLNITROSAMINE; INTERLEUKIN 6; NANOCAPSULE; QUERCETIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME INHIBITION; HISTOPATHOLOGY; INTERFERON PRODUCTION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; MALE; NANOENCAPSULATION; NONHUMAN; OXIDATIVE STRESS; PRECANCER; RAT; UPREGULATION; ANIMAL; ATOMIC FORCE MICROSCOPY; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; DIETHYLNITROSAMINE; DOWN-REGULATION; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 13; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOCAPSULES; QUERCETIN; RATS;

EID: 84912061561     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.11     Document Type: Article

References (51)

1. Sawada Y, Yoshikawa T, Nobuoka D et al. Phase 1 trial of glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunological evidence and potential for improving overall survival. Clin. Cancer Res. 18, 3686-3696 (2012).
2. Ward JM, Shibata MA, Devor DE. Emerging issues in mouse liver carcinogenesis. Toxicol. Pathol. 24, 129-137 (1996).
3. Jeng KS, Sheen IS, Jeng WJ. Azidothymidine treatment of hepatocellular carcinoma in rats: an in vivo study of telomerase inhibition. Hepatogastroenterology 58, 2091-2096 (2011).
4. Cuesta S, Kireev R, Garcia C et al. Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model. Mech. Ageing Dev. 132, 573-582 (2011).
5. Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic. Biol. Med. 52, 2013-2037 (2012).
6. Mandal AK, Das S, Mitra M, Chakrabarti RN, Chatterjee M, Das N. Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model. J. Exp. Ther. Oncol. 7, 123-133 (2008).
7. Aitio A, Aitio ML, Camus AM, Cardis E, Bartsch H. Cytochrome P-450 isozyme pattern is related to individual susceptibility to diethylnitrosamine-induced liver cancer in rats. Jpn J. Cancer Res. 82, 146-156 (1991).
8. Ezquer M, Ezquer F, Ricca M, Allers C, Conget P. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J. Hepatol. 55, 1112-1120 (2011).
9. Monk JM, Kim W, Callaway E et al. Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARd in inflammation-induced colon carcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G153-G167 (2012).
10. Anson M, Crain-Demoyelle AM, Baud V et al. Oncogenic b-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J. Clin. Invest. 122, 586-599 (2012).
11. Leonardi GC, Candido S, Cervello M et al. The tumor microenvironment in hepatocellular carcinoma (review). Int. J. Oncol. 40, 1733-1747 (2012).
12. Mazzantini RP, de Conti A, Moreno FS. Persistent and remodelling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl-2 and NF-kappa B pathways. J. Cell Biochem. 103, 538-546 (2008).
13. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7, 1434-1441 (1993).
14. Bergers G, Javaherian K, Lo K, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812 (1999).
15. Coussens ML, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392 (2002).
16. Johansson N, Ahonen M, Kahari VM. Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci. 57, 5-15 (2000).
17. Mandal AK, Das N. Sugar coated liposomal flavonoid: a unique formulation in combating carbontetrachloride induced hepatic oxidative damage. J. Drug Target. 13, 305-315 (2005).
18. Ghosh A, Ghosh D, Sarkar S, Mandal AK, Thakur Choudhury S, Das N. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats. Eur. J. Cancer Prev. 21, 32-41 (2012).
19. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quercetin, a potent inhibitor against beta-catenin/Tcf signalling in SW480 colon cancer cells. Biochem. Biophys. Res. Commun. 328, 227-234 (2005).
20. Byrne J, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60,1615-1626 (2008).
21. Parveen S, Sahoo S. Polymeric nanoparticles for cancer therapy. J. Drug Target.16,108-123 (2008).
22. Brannon-Peppas L, Blanchette J. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, 1649-1659 (2004).
23. Ghosh D, Ghosh S, Sarkar S et al. Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chem. Biol. Interact. 186, 61-71 (2010).
24. Kim SW, Park KC, Kim, HJ et al. Effects of collagen IV and laminin on the reconstruction of human oral mucosa. J. Biomed. Mater Res. 58, 108-112 (2001).
25. Chowdhury AR, Mandal S, Goswami A et al. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy. Mol. Med. 9, 26-36 (2003).
26. Hariharan S, Bhardwaj V, Bala L, Sitterberg J, Bakowasky U, Kumar MNVR. Design of estradiol loaded PLGA nano particulate formulations: a potential oral delivery system for hormone therapy. Pharm. Res. 23, 184-195 (2006).
27. Opresko L, Wiley HS, Wallace RA. Proteins iodinated by the chloramines-T method appear to be degraded at an abnormally rapid rate after endocytosis. Proc. Natl Acad. Sci. USA 77, 1556-1560 (1980).
28. Changtam C, de Koning HP, Ibrahim H et al. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur. J. Med. Chem. 45, 941-956 (2010).
29. Wina KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly (d, l-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27, 2285-2291 (2006).
30. Sarkar S, Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech. Age. Develop. 127, 391-397 (2006).
31. Moragón AC, De Lucas García N, Encarnación López Fernández M, Rodriguez-Manzaneque AS, Jimenez Fraile JA. Antioxidant enzymes, occupational stress and burnout in workers of a prehospitalary emergency service. Eur. J. Emerg. Med. 12, 111-115 (2005).
32. Maiti S, Chatterjee AK. Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ. Tox. Pharm. 8, 227-235 (2000).
33. Mandal AK, Sinha J, Mandal S, Mukhopadhyay S, Das N. Targeting of liposomal flavonoid to liver in combating hepatocellular oxidative damage. Drug Deliv. 9, 181-185 (2002).
34. Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478 (1990).
35. Jones BL, Fontanini D, Jarvinen M, Pekkarinen A. Simplified endoproteinase assays using gelatin or azogelatin. Anal. Biochem. 263, 214-220 (1998).
36. Lowry OH, Rosebrough NJ, Farr AL, Randel R. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-277 (1951).
37. Socha M, Bartecki P, Passirani C et al. Stealth nanoparticles coated with heparin as peptide or protein carriers. J. Drug Target. 17, 575-585 (2009).
38. De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 3, 133-149 (2008).
39. Umoh NJ, Lesi OA, Mendy M et al. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver Int. 31, 215-221 (2011).
40. Bishayee A, Sarkar A, Chatterjee M. Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and Phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid. Nutr. Cancer 37, 89-98 (2000)
41. Dasari A, Bartholonew JN, Volonte D, Galbiati F. Oxidative stress induces premature scnescence by stimulating caveolin 1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res. 66, 10805-10814 (2006).
42. Zhi-Ping Y, Li-Juan C, Lin-Yu F et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res. 12, 3193-3199 (2006).
43. Shimamoto K, Hayashi H, Taniai E et al. Antioxidant N-acetyl-L-cysteine (NAC) supplementation reduces reactive oxygen species (ROS)-mediated hepatocellular tumor promotion of indole-3-carbinol (13C) in rats. J. Toxicol. Sci. 36, 775-786 (2011).
44. Teufelhofer O, Weiss RM, Parzefall W et al. Promyelocytic HL60 cells express NADPH oxidase and are excellent targets in a rapid spectrophotometric microplate assay for extracellular superoxide. Toxicol. Sci. 76, 376-383 (2003).
45. Savitha S, Tamilselvan J, Anusuyadevi M, Panneerselvam C. Oxidative stress on mitochondrial antioxidant defense system in the aging process: role of DL -alpha-lipoic acid and L-carnitine. Clin. Chem. Acta. 355, 173-180 (2005).
46. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 5, 14 (2006).
47. Jayakumar S, Madankumar A, Asokkumar S et al. Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol. Cell Biochem. 360, 51-60 (2012).
48. Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J. Gastroenterol. Hepatol. 27, 89-93 (2012).
49. Liu M, Liu H, Wang X, Chen P, Chen H. IL-6 induction of hepatocyte proliferation through the Tmub1-regulated gene pathway. Int. J. Mol. Med. 29, 1106-1112 (2012).
50. Lee J, Lim KT. Inhibitory effect of phytoglycoprotein (24kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice. J. Pharm. Pharmacol. 63, 840-848 (2011).
51. Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis. Oncology 81, 24-29 (2011).